Treatment with 1% DFMO in water given to NZB/W mice (a lupus-prone model) reduced IgG and IgA levels in the mice and reduced spermidine and putrescine levels suggesting the inhibition of ODC as a promising avenue for SLE therapeutics [69]. Here, ODC1 is linked to systemic lupus erythematosus.